SEC Form D Coverage: 480 Biomedical $6.00 million Financing. Maria Palasis Released Nov 28 form D

480 Biomedical, Inc. - Maria Palasis

480 Biomedical Financing

480 Biomedical, Inc., Corporation just filed form D regarding $6.00 million equity financing. This is a new filing. 480 Biomedical was able to sell $6.00 million. That is 100.00% of the offering. The total offering amount was $6.00 million. The private financing document was filed on 2016-11-28. The reason for the financing was: unspecified.

480 Biomedical is based in Massachusetts. The firm’s business is not disclosed. The form D was signed by Maria Palasis President and Chief Executive Officer. The company was incorporated more than five years ago. The filler’s address is: 480 Arsenal Street, Watertown, Ma, Massachusetts, 02472. Dennis Dougherty is the related person in the form and it has address: 480 Arsenal Street, Watertown, Ma, Massachusetts, 02472. Link to 480 Biomedical Filing: 000114036116087933.

Analysis of 480 Biomedical Offering

On average, companies in the not disclosed sector, sell 67.77% of the total offering size. 480 Biomedical sold 100.00% of the offering. Could this mean that the trust in 480 Biomedical is high? The average fundraising size for companies in all industries in our database is $3.05 million. The total amount raised is 96.72% bigger than the average for companies in the database. The minimum investment for this offering is set at $0. If you know more about the reasons for the financing, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For 480 Biomedical Also

The Form D signed by Maria Palasis might help 480 Biomedical, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment